{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:25:14Z","timestamp":1788805514355,"version":"build-2803163510"},"reference-count":65,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Guillain-Barr\u00e9 syndrome (GBS) can occur at all stages of human immunodeficiency virus (HIV) infection. HIV, cytomegalovirus (CMV), and varicella zoster virus (VZV) are the main infectious agents in HIV-positive GBS cases. These cases include acute and chronic HIV infection, immune reconstitution inflammatory syndrome (IRIS) shortly after anti-retroviral therapy (ART), those with ART interruption, or those with cerebrospinal fluids (CSF) HIV escape. The mechanisms are involved in both humoral and cellular immunities. Demyelinating and axonal neuropathies are the main pathological mechanisms in GBS. Presentation and prognosis are identical to those in patients without HIV infection. Typical or atypical clinical manifestations, CSF analysis, electrophysiological and pathological examination, and antiganglioside antibody detection can help diagnose GBS and classify its various subtypes. Intravenous immunoglobulin and plasma exchange have been used to treat GBS in HIV-positive patients with a necessary ART, while ganciclovir or foscarnet sodium should be used to treat ongoing CMV- or VZV-associated GBS. Steroids may be beneficial for patients with IRIS-related GBS. We reviewed HIV-positive cases with GBS published since 2000 and summarized their features to highlight the necessity of HIV testing among patients with GBS. Moreover, the establishment of a multidisciplinary team will guarantee diagnostic and therapeutic advantages.<\/jats:p>","DOI":"10.3390\/jcm12030907","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T01:59:03Z","timestamp":1674525543000},"page":"907","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Peculiarity of Infection and Immunity Correlated with Guillain-Barr\u00e9 Syndrome in the HIV-Infected Population"],"prefix":"10.3390","volume":"12","author":[{"given":"Yanli","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, Shenyang 110001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Neurology Department, The First Affiliated Hospital of China Medical University, Shenyang 110001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, Shenyang 110001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1086\/374935","article-title":"Miller Fisher Variant of Guillain-Barre Syndrome Associated with Lactic Acidosis and Stavudine Therapy","volume":"36","author":"Shah","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/01.inf.0000076600.83640.3e","article-title":"Fatal lactic acidosis and mimicking Guillain-Barr\u00e9 syndrome in an adolescent with human immunodeficiency virus infection","volume":"22","author":"Rosso","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000322573","article-title":"Antiretroviral Therapy-Associated Acute Motor and Sensory Axonal Neuropathy","volume":"3","author":"Capers","year":"2011","journal-title":"Case Rep. Neurol."},{"key":"ref_5","first-page":"1067","article-title":"HIV drug stavudine (Zerit, d4T) and symptoms mimicking Guillain-Barr\u00e9 syndrome","volume":"166","author":"Wooltorton","year":"2002","journal-title":"CMAJ"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"833548","DOI":"10.3389\/fimmu.2022.833548","article-title":"Post-Infectious Autoimmunity in the Central (CNS) and Periph-eral (PNS) Nervous Systems: An African Perspective","volume":"13","author":"Ndondo","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/08998280.2015.11929176","article-title":"Ascending Paralysis Associated with Hiv Infection","volume":"28","author":"Afzal","year":"2015","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.2169\/internalmedicine.50.5883","article-title":"Antiretroviral therapy for treatment-na\u00efve chronic HIV-1 infec-tion with an axonal variant of Guillain-Barr\u00e9 syndrome positive for anti-ganglioside antibody: A case report","volume":"50","author":"Nishijima","year":"2011","journal-title":"Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0037-86822010000100019","article-title":"Chronic inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alpha 2b in a patient with HIV\/HCV coinfection: Case report","volume":"43","author":"Bassetti","year":"2010","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s15010-011-0184-7","article-title":"Miller-Fisher syndrome following vaccination against influ-enza virus A\/H1N1 in an AIDS patient","volume":"40","author":"Annunziata","year":"2012","journal-title":"Infection"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hou, H.Q., Miao, J., Feng, X.D., Han, M., Song, X.J., and Guo, L. (2014). Changes in lymphocyte subsets in patients with Guil-lain-Barr\u00e9 syndrome treated with immunoglobulin. BMC Neurol., 14.","DOI":"10.1186\/s12883-014-0202-3"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/jnnp-2019-322479","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barr\u00e9 syndrome","volume":"91","author":"Koike","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2018.04.026","article-title":"Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barr\u00e9 Syndrome","volume":"110","author":"Debnath","year":"2018","journal-title":"Cytokine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1179\/joc.2001.13.5.575","article-title":"Role of Gancyclovir and HAART Administration in the Treatment of a Rare Complication of HIV Disease: Cytomegalovirus-Associated Guillain-Barr\u00e9 Syndrome","volume":"13","author":"Calza","year":"2001","journal-title":"J. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1590\/S0004-282X2006000400016","article-title":"Episodes of Guillain-Barr\u00e9 syndrome associat-ed with the acute phase of HIV-1 infection and with recurrence of viremia","volume":"64","author":"Bastos","year":"2006","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/jinf.2001.0917","article-title":"Recurrent Guillain-Barre syndrome as a com-plication of immune reconstitution in HIV","volume":"44","author":"Makela","year":"2002","journal-title":"J. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.10645","article-title":"Schwann cell chemokine receptors me-diate HIV-1 gp120 toxicity to sensory neurons","volume":"54","author":"Keswani","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.virol.2005.01.027","article-title":"Peripheral nerve-derived HIV-1 is predominantly CCR5-dependent and causes neuronal degeneration and neuroinflammation","volume":"334","author":"Jones","year":"2005","journal-title":"Virology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"102665","DOI":"10.1016\/j.autrev.2020.102665","article-title":"Genetic polymorphisms in Guillain-Barr\u00e9 Syndrome: A field synopsis and systematic meta-analysis","volume":"19","author":"Zhao","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_23","first-page":"62","article-title":"Guillain-Barre syndrome following immune reconsti-tution after antiretroviral therapy for primary HIV infection","volume":"12","author":"Teo","year":"2007","journal-title":"J. HIV Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/cid\/cix1063","article-title":"Acute Retroviral Syndrome Is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments","volume":"66","author":"Crowell","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/1752-1947-2-370","article-title":"Human immunodeficiency virus serocon-version presenting with acute inflammatory demyelinating polyneuropathy: A case report","volume":"2","author":"Sloan","year":"2008","journal-title":"J. Med. Case Rep."},{"key":"ref_26","first-page":"1","article-title":"Guillain-Barr\u00e9 Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report","volume":"2011","author":"Pontali","year":"2011","journal-title":"Case Rep. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e005107","DOI":"10.1099\/jmmcr.0.005107","article-title":"HIV positive patient with GBS-like syndrome","volume":"4","author":"Shepherd","year":"2017","journal-title":"JMM Case Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.eimc.2021.09.001","article-title":"Guillain-Barr\u00e9-like syndrome as a rare presen-tation of severe primary HIV-infection","volume":"39","author":"Marcos","year":"2021","journal-title":"Enferm. Infecc. Y Microbiol. Clin. (Engl. Ed)"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/313810","article-title":"Neurological Symptoms during Primary Human Immunodeficiency Virus (HIV) Infection Correlate with High Levels of HIV RNA in Cerebrospinal Fluid","volume":"30","author":"Tambussi","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/00002030-200207260-00017","article-title":"Acute Guillain\u2013Barr\u00e9 syndrome during the chronic phase of HIV infection and dramatic improvement under highly active antiretroviral therapy","volume":"16","author":"Neuville","year":"2002","journal-title":"Aids"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/00365540500277227","article-title":"Temporarily controlled HIV-1 replication after in-travenous immunoglobulin treatment of Guillain-Barr\u00e9 syndrome","volume":"37","author":"Fredman","year":"2005","journal-title":"Scand J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/jac\/dkz573","article-title":"Acute inflammatory demyelinating polyneuropathy following interruption of antiretroviral treatment and HIV rebound","volume":"75","author":"Malano","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0009922819898186","article-title":"Guillain-Barr\u00e9 Syndrome in a Teenage Girl: A Severe Case with Anti-GM2 Antibodies Associated with Acute CMV Infection and Literature Review","volume":"59","author":"Silva","year":"2019","journal-title":"Clin. Pediatr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1080\/21645515.2021.1985890","article-title":"Risk of Guillain-Barr\u00e9 syndrome following herpes zoster, United States, 2010\u20132018","volume":"17","author":"Anderson","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14787210.2015.1029917","article-title":"Opportunistic infections and immune re-constitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: A comprehensive review","volume":"13","author":"Manzardo","year":"2015","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"ref_36","first-page":"bcr-2017","article-title":"Worsening Guillain-Barr\u00e9 syndrome: Harbinger of IRIS in HIV?","volume":"2017","author":"Mathukumalli","year":"2017","journal-title":"BMJ Case Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1086\/368311","article-title":"Guillain-Barre Syndrome Associated with Immune Reconstitution","volume":"36","author":"Piliero","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","first-page":"103","article-title":"Guillain Barre syndrome in an HIV-1-infected patient after the beginning of combined antiretroviral therapy: An immune reconstitution inflammatory syndrome?","volume":"37","author":"Fantauzzi","year":"2014","journal-title":"New Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2017.09.044","article-title":"Fluctuating ataxia and nystagmus in association with anti-GQ1b antibody in HIV infection","volume":"382","author":"Jung","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"102368","DOI":"10.1016\/j.bjid.2022.102368","article-title":"Guillain-Barr\u00e9 syndrome spectrum as manifestation of HIV-related immune reconstitution inflammatory syndrome: Case report and literature review","volume":"26","author":"Vidal","year":"2022","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.17712\/nsj.2021.3.20200178","article-title":"Clinical and biochemical profile of Guillain Barr\u00e9 Syn-drome in Pakistan","volume":"26","author":"Iqbal","year":"2021","journal-title":"Neurosciences (Riyadh)"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.intimp.2015.09.023","article-title":"Intravenous immunoglobulin treatment in a HIV-1 positive patient with Guil-lain-Barr\u00e9 syndrome","volume":"29","author":"Rosca","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1097\/QAD.0000000000002253","article-title":"What can characterization of cerebrospinal fluid escape populations teach us about viral reservoirs in the central nervous system?","volume":"33","author":"Joseph","year":"2019","journal-title":"AIDS"},{"key":"ref_44","first-page":"139","article-title":"Guillain-Barr\u00e9 Syndrome with HIV Infection: A Case Report","volume":"12","author":"Ting","year":"2003","journal-title":"Acta Neurologica. Taiwanica"},{"key":"ref_45","first-page":"559","article-title":"Guillain-Barre syndrome presenting in the an-ti-HIV seroconversion period","volume":"51","author":"Kumar","year":"2003","journal-title":"Neurol. India"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3760\/cma.j.issn.0366-6999.20131338","article-title":"HIV seroconversion manifesting as Guillian-Barre syndrome","volume":"127","author":"Varshney","year":"2014","journal-title":"Chin. Med. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12691\/ajmcr-7-1-2","article-title":"A Rare Case of HIV-Induced Inflammatory Demyelinating Polyneuropa-thy","volume":"7","author":"Sajan","year":"2019","journal-title":"Am. J. Med. Case Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-510X(02)00418-5","article-title":"HIV-associated Guillain-Barr\u00e9 syndrome","volume":"208","author":"Brannagan","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/CND.0b013e31815afaac","article-title":"HIV Infection Presenting With Motor Axonal Variant of Guillain-Barr\u00e9 Syndrome","volume":"9","author":"Wagner","year":"2007","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2007.02.029","article-title":"Fisher\/Gullain-Barr\u00e9 overlap syn-drome in advanced AIDS","volume":"258","author":"Hiraga","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rehab.2011.09.009","article-title":"Functional recovery of untreated human immunodeficiency vi-rus-associated Guillain-Barr\u00e9 syndrome: A case report","volume":"54","author":"Schreiber","year":"2011","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5152\/TJAR.2013.51","article-title":"Guillain-Barr\u00e9 Syndrome and Human Immunodefi-ciency Virus","volume":"42","author":"Girgin","year":"2014","journal-title":"Turk. J. Anaesthesiol. Reanim."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12098-013-1171-z","article-title":"Acute Motor Axonal Neuropathy in HIV Infection","volume":"81","author":"Jadhav","year":"2013","journal-title":"Indian J. Pediatr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/omcr\/omv009","article-title":"Acute motor axonal neuropathy in a patient with prolonged CD4 depletion due to HIV: A local variant of macrophage activation syndrome?","volume":"2015","author":"Dardis","year":"2015","journal-title":"Oxf. Med. Case Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lopes, M., Marques, P., Silva, B., Cruz, G., Serra, J.E., Ferreira, E., Alves, H., and da Cunha, J. (2021). Guillain-Barr\u00e9 syndrome as the first presentation of human immunode-ficiency virus infection. BMC Neurol., 21.","DOI":"10.1186\/s12883-021-02350-1"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1529-8027.2000.00014.x","article-title":"Chronic inflammatory demyelinating polyneuropathy caused by HIV infection in a patient with asymptomatic CMT 1A","volume":"5","author":"Rajabally","year":"2000","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00381-010-1197-8","article-title":"Magnetic resonance imaging of child-hood Guillain-Barre syndrome","volume":"26","author":"Yikilmaz","year":"2010","journal-title":"Childs Nerv. Syst."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s150100050067","article-title":"Cerebrospinal fluid antibodies directed against neuron-associated gan-gliosides in HIV-1 infection","volume":"28","author":"Lekman","year":"2000","journal-title":"Infection"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF01716288","article-title":"Cerebrospinal fluid antiganglioside antibodies in patients with AIDS","volume":"23","author":"Sorice","year":"1995","journal-title":"Infection"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.imlet.2005.02.018","article-title":"Alterations of self-reactive antibody repertoires in HIV disease: An insight into the role of T cells in the selection of autoreactive B cells","volume":"99","author":"Stahl","year":"2005","journal-title":"Immunol. Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000013139","article-title":"Predicting Outcome in Guillain-Barr\u00e9 Syndrome: International Validation of the Modified Erasmus GBS Outcome Score","volume":"98","author":"Doets","year":"2022","journal-title":"Neurology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.26312","article-title":"International Validation of the Erasmus Guillain\u2013Barr\u00e9 Syndrome Respiratory Insufficiency Score","volume":"91","author":"Doets","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_64","first-page":"938","article-title":"Biological Drugs in Guillain-Barr\u00e9 Syndrome: An Update","volume":"15","author":"Matin","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3389\/fneur.2020.00865","article-title":"A Pilot Study on Serial Nerve Ultrasound in Miller Fisher Syn-drome","volume":"11","author":"Hsueh","year":"2020","journal-title":"Front. Neurol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/3\/907\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:14:17Z","timestamp":1760120057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/3\/907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["jcm12030907"],"URL":"https:\/\/doi.org\/10.3390\/jcm12030907","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}